Cognitive and non-cognitive behaviors in an APPswe/PS1 bigenic model of Alzheimer's disease

被引:95
|
作者
Filali, M. [1 ,2 ]
Lalonde, R. [3 ,4 ]
Rivest, S. [1 ,2 ]
机构
[1] CHU Laval, Ctr Rech, CHUQ, Mol Endocrinol Lab, Quebec City, PQ G1V 4G2, Canada
[2] Univ Laval, Dept Anat & Physiol, Quebec City, PQ, Canada
[3] Ctr Hosp Univ Montreal St Luc, Unite Rech Sci Neurol, Montreal, PQ, Canada
[4] Univ Rouen, Fac Sci, Rouen, France
关键词
Alzheimer's disease; APPswe; PS1; depressive-like behavior; forced swim test; nesting behavior; social disinhibition; T-water maze; AMYLOID PRECURSOR PROTEIN; DOUBLE TRANSGENIC MICE; MOUSE MODEL; MEMORY; BETA; DEPOSITION; DEFICITS; BRAIN; PRESENILIN-1; DYSFUNCTION;
D O I
10.1111/j.1601-183X.2008.00453.x
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Neuropsychiatric signs are critical in primary caregiving of Alzheimer patients and yet have been relatively ignored in murine models. In the present study, APPswe/PS1 bigenic mice had higher levels of irritability than non-transgenic controls as measured in the touch escape test. Moreover, APPswe/PS1 mice showed poorer nest building than controls and a higher duration of immobility in the forced swimming assay. These results are concordant with the hypothesis of increased apathy and depression-like behavior in an Alzheimer's disease model. In addition, APPswe/PS1 bigenic mice were deficient in retention of passive avoidance learning and left-right discrimination learning, concordant with previous findings in other Alzheimer-like models.
引用
收藏
页码:143 / 148
页数:6
相关论文
共 50 条
  • [21] Apolipoprotein E polymorphism and non-cognitive symptoms in Alzheimer's disease
    Gabryelewicz, T
    Styczynska, M
    Pfeffer, A
    Luczywek, E
    Wasiak, B
    Czyzewski, K
    Barcikowska, M
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S368 - S368
  • [22] Partial Endothelial Nitric Oxide Synthase Deficiency Exacerbates Cognitive Deficit and Amyloid Pathology in the APPswe/PS1ΔE9 Mouse Model of Alzheimer's Disease
    Ahmed, Sara
    Jing, Yu
    Mockett, Bruce G.
    Zhang, Hu
    Abraham, Wickliffe C.
    Liu, Ping
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (13)
  • [23] The association of non-cognitive symptoms and functional impairment in Alzheimer's disease
    Winnie, MW
    NEUROBIOLOGY OF AGING, 2004, 25 : S121 - S121
  • [24] TRANSCRIPTOMICS OF AGGRAVATED EPILEPTOGENESIS AND COGNITIVE DECLINE AFTER TBI IN APP/PS1 MOUSE MODEL OF ALZHEIMER'S DISEASE
    Pitkanen, Asla
    Miszczuk, Diana
    Debski, Kondrad
    Tanila, Heikki
    Lukasiuk, Katarzyna
    JOURNAL OF NEUROTRAUMA, 2015, 32 (12) : A77 - A77
  • [25] Prevalence and management of non-cognitive symptoms of Alzheimer's disease.
    RAiner, M
    Anderle, E
    Masching, A
    Sepandj, A
    Haushofer, M
    NEUROPSYCHIATRIE, 1996, 10 (03): : 161 - 163
  • [26] The role of ADAM17 in cerebrovascular and cognitive function in the APP/PS1 mouse model of Alzheimer's disease
    Tian, Yanna
    Fopiano, Katie Anne
    Buncha, Vadym
    Lang, Liwei
    Suggs, Hayden A.
    Wang, Rongrong
    Rudic, R. Daniel
    Filosa, Jessica A.
    Bagi, Zsolt
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2023, 16
  • [27] Microvascular ultrastructural changes precede cognitive impairment in the murine APPswe/PS1dE9 model of Alzheimer’s disease
    Patricia Kelly
    Paul Denver
    Simon C. Satchell
    Maximilian Ackermann
    Moritz A. Konerding
    Christopher A. Mitchell
    Angiogenesis, 2017, 20 : 567 - 580
  • [28] CEREBRAL AND SYSTEMIC MICROANGIOARCHITECTURAL IMPAIRMENTS PRECEDE COGNITIVE DEFICITS IN AN APP/PS1 MOUSE MODEL OF ALZHEIMER'S DISEASE
    Kelly, P.
    Ackermann, M.
    Konerding, M.
    Mitchell, C.
    JOURNAL OF VASCULAR RESEARCH, 2015, 52 : 72 - 72
  • [29] Novel behavioural characteristics of the APPSwe/PS1ΔE9 transgenic mouse model of Alzheimer's disease
    Cheng, David
    Logge, Warren
    Low, Jac Kee
    Garner, Brett
    Karl, Tim
    BEHAVIOURAL BRAIN RESEARCH, 2013, 245 : 120 - 127
  • [30] Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease
    Ballard, C
    Massey, H
    Lamb, H
    Morris, C
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 63 (02): : 273 - 274